| Known as |
Tocofersolan |
ClinicalTrials.gov intervention name — accepted as the source's own label NCT01457690 ↗1NCT03582384 ↗
|
| Known as |
Liqui-e |
ChEMBL registry synonym — accepted as the source's own label CHEMBL2108106 ↗
|
| Known as |
Tocophersolan |
ChEMBL registry synonym — accepted as the source's own label CHEMBL2108106 ↗
|
| Known as |
TPG-S |
ChEMBL registry synonym — accepted as the source's own label CHEMBL2108106 ↗
|
| Known as |
Vedrop |
“Use of Tocofersolan (Vedrop®) to Prevent or Treat Refractive Vitamin E Deficiency in Infants and Children” NCT03582384 ↗
|
| Known as |
Vitamin e polyethylene glycol succinate |
ChEMBL registry synonym — accepted as the source's own label CHEMBL2108106 ↗
|
| Modality |
Small molecule |
— CHEMBL2108106 ↗
|
| Route |
Oral |
“The aims of this study were to evaluate the intestinal absorption characteristics of tocofersolan versus α-tocopherol acetate by measuring the plasma concentrations of...” PMID 30021760 ↗ Jul 2018
|